Segal Francis David has made a notable stock transaction involving 335 shares of Ingevity Corp, valued at $71.09 each. This acquisition, reported in a recent SEC filing, underscores the commitment of directors to the company's performance and aligns with industry practices regarding executive ownership.
Background
Segal Francis David is a director at Ingevity Corp, a company classified under the chemicals and allied products sector. The most recent filing was submitted on October 2, 2026, detailing the transaction that took place on October 1, 2026. Ingevity Corp is publicly traded under the ticker symbol NGVT and is listed on the New York Stock Exchange.
What the Filing Says
The SEC filing indicates that Segal acquired 335 shares of Ingevity Corp on October 1, 2026. Following this transaction, Segal now owns a total of 8,947 shares. The filing notes, "Represents vested deferred stock units ('DSUs') granted pursuant to the reporting person's election to receive DSUs in lieu of quarterly director fees." These DSUs will convert into shares upon Segal's termination of board service.
Impact
This transaction may influence perceptions of leadership engagement within Ingevity Corp and could encourage further investment from other directors and stakeholders in the chemicals industry. The filing highlights the importance of director ownership in fostering trust and confidence among investors.
What's Next
The filing does not say what happens next.